Hamlet BioPharma Participates in the BioStock Life Science Summit 2024

Hamlet Biopharma
|
October 8, 2025

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces its participation in the BioStock Life Science Summit, set to take place in Lund, Sweden, on November 20-21, 2024. The company will present at 1:30 pm on Wednesday the 20th of November.

For more information about BioStock Life Science Summit 2024, please visit BioStock Life Science Summit 2024 web page.

For further information, please contact:

Catharina Svanborg, Chairman and Founder of Hamlet BioPharma, +46-709 42 65 49

catharina.svanborg@hamletpharma.com

Martin Erixon, CEO Hamlet BioPharma, +46-733 00 43 77

martin.erixon@hamletpharma.com

Related Documents
Recent posts
An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.
Hamlet BioPharma AB
Klinikgatan 32
SE-222 42 Lund
info@hamletbiopharma.com
Org. no. 556568-8958
Subscribe to receive newsletters
© 2025
Hamlet BioPharma.